🔎 Trials Near Me

Akèy › Kansè tete negatif triple › Michigan › Detroit

Etid klinik pou Kansè tete negatif triple nan Detroit, MI

9 etid pou Kansè tete negatif triple ap chèche patisipan nan sit nan ak bò kote Detroit (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

Ap rekriteFaz 3
  • Henry Ford Health ( Site 0010), Detroit
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06393374

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Ap rekriteFaz 1/2
  • Karmanos Cancer Institute, Detroit
Laj 18 ak plis · Tout sèks · Mizajou Aug 4, 2026 · NCT05579366

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

Ap rekriteFaz 1
  • Karmanos Cancer Institute, Detroit
Laj 18 ak plis · Tout sèks · Mizajou Jul 22, 2026 · NCT05208762

A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

Ap rekriteFaz 1/2
  • Henry Ford Health Hospital, Detroit
Laj 18 ak plis · Tout sèks · Mizajou Jun 29, 2026 · NCT05377996

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

Ap rekriteFaz 1
  • Karmanos Cancer Institute, Detroit
Laj 18 ak plis · Tout sèks · Mizajou Jun 18, 2026 · NCT07503808

JAB-2485 Activity in Adult Patients With Advanced Solid Tumors

Ap rekriteFaz 1/2
  • Henry Ford Health System, Detroit
Laj 18 ak plis · Tout sèks · Mizajou Jan 9, 2026 · NCT05490472

A Beta-only IL-2 ImmunoTherapY Study

Ap rekriteFaz 1/2
  • Karmanos Cancer Institute, Detroit
Laj 18 ak plis · Tout sèks · Mizajou Jul 9, 2025 · NCT05086692

Etid Kansè tete negatif triple nan lòt vil

Lòt etid nan Detroit

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.